Provided by Tiger Fintech (Singapore) Pte. Ltd.

Capricor Therapeutics

6.88
-0.2800-3.91%
Post-market: 6.920.0400+0.58%19:59 EDT
Volume:2.10M
Turnover:14.76M
Market Cap:314.47M
PE:-4.85
High:7.27
Open:7.15
Low:6.88
Close:7.16
Loading ...

Positive Outlook on Capricor Therapeutics Despite Regulatory Setbacks

TIPRANKS
·
15 Jul

Capricor Therapeutics Is Maintained at Buy by Roth Capital

Dow Jones
·
15 Jul

Capricor Therapeutics price target lowered to $16 from $20 at Alliance Global

TIPRANKS
·
14 Jul

Capricor Therapeutics Stock (CAPR) Plummets 40% on FDA Rejection

TIPRANKS
·
12 Jul

Capricor Therapeutics Down 33%, on Pace for Largest Percent Decrease Since September 2023 -- Data Talk

Dow Jones
·
12 Jul

Capricor Therapeutics Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
12 Jul

BUZZ-U.S. STOCKS ON THE MOVE-AeroVironment, Civista Bancshares, Meta

Reuters
·
12 Jul

Capricor data in Q3 should support resubmission, says JonesResearch

TIPRANKS
·
11 Jul

Capricor Therapeutics price target lowered to $24 from $77 at H.C. Wainwright

TIPRANKS
·
11 Jul

Capricor Therapeutics, Inc. : H.c. Wainwright Cuts Target Price to $24 From $77

THOMSON REUTERS
·
11 Jul

Capricor Therapeutics Shares Down 38.3% After FDA Declines to Approve Co's Cell Therapy

THOMSON REUTERS
·
11 Jul

Morning Movers: Capricor Therapeutics plunges following CRL from FDA

TIPRANKS
·
11 Jul

Exchange-Traded Funds, Equity Futures Lower Pre-Bell Friday After Surprise Tariff Hikes

MT Newswires Live
·
11 Jul

Top Premarket Decliners

MT Newswires Live
·
11 Jul

BUZZ-U.S. STOCKS ON THE MOVE-Levi Strauss, Crypto Stocks, Delta

Reuters
·
11 Jul

Capricor Therapeutics Shares Plunge Premarket on FDA Setback

Dow Jones
·
11 Jul

Capricor reports FDA unable to approve deramiocel BLA in current form

TIPRANKS
·
11 Jul

US FDA declines to approve Capricor's muscle disorder therapy

Reuters
·
11 Jul

Capricor Therapeutics Shares Down 40.4% Premarket After FDA Declines to Approve Co's Cell Therapy

THOMSON REUTERS
·
11 Jul

BRIEF-Capricor Therapeutics Provides Regulatory Update On Deramiocel BLA For Duchenne Muscular Dystrophy

Reuters
·
11 Jul